J Matern Fetal Neonatal Med. 2025 Dec;38(1):2547395. doi: 10.1080/14767058.2025.2547395. Epub 2025 Oct 28.
ABSTRACT
OBJECTIVE: To explore the establishment and application of an early warning scoring system for neonatal pneumonia based on information technology.
METHODS: A total of 140 neonates with pneumonia admitted to our hospital from July 2020 to December 2023 were selected as study subjects. They were randomly divided into a control group (routine care, n = 70) and an observation group (care under an early warning mechanism integrated into the hospital’s electronic health record (EHR) system, which provided real-time alerts to the medical staff, n = 70). The time to symptom resolution was compared between the two groups. An assessment of respiratory status using the Neonatal Respiratory Distress Score (NRDS) and blood gas analysis indicators were compared before (within 1 h of enrollment) and 1 week after care. Incidence of complications was also recorded and analyzed.
RESULTS: There was no significant difference in birth time, gender, weight, disease course, and mode of delivery between the two groups (p > 0.05). Significant differences were observed in the time to disappearance of cough, dyspnea, pulmonary rales, return to normal temperature, and relief of respiratory distress between the two groups (p < 0.05). Before care (within 1 h), there was no significant difference in NRDS levels between the two groups (p > 0.05). However, one week after care, the NRDS was significantly lower in the observation group than in the control group (p < 0.001). Similarly, oxygen saturation (SpO2), partial pressure of arterial oxygen (PaO2), and arterial oxygen saturation (SaO2) levels were significantly higher in the observation group while partial pressure of arterial carbon dioxide (PaCO2) level was significantly lower compared to the control group one week after care (p < 0.001).
CONCLUSION: The application of an early warning scoring system for neonatal pneumonia based on information technology can shorten the time to symptom resolution, improve respiratory status, normalize blood gas indices, and reduce the incidence of complications.
PMID:41151999 | DOI:10.1080/14767058.2025.2547395
